Raleigh’s Sprout Pharmaceuticals, makers of ‘female viagra,’ raise $15.9M
The round is capped at $20 million, with $4.1 million remaining to be sold.
Read More
sprout pharmaceuticals
‘Female Viagra’ firm’s CEO: New rival drug will ‘further propel’ growth
Cindy Eckert, CEO of Raleigh-based Sprout Pharmaceuticals is welcoming news that her firm’s so-called “female Viagra” now has competition in the market to deal with female sexual disfunction.
Read More
FDA approves rival for ‘female Viagra’ from Raleigh firm Sprout Pharmaceuticals
The move creates a rival for Addyi, the first such drug approved for women. It is made by Raleigh-based Sprout Pharmaceuticals and is known as the “female Viagra.”
Read MoreTech on Tap: Apple’s Streaming Announcement, Duke Energy on Electric Vehicles, Bird and Lime leave Raleigh, IBM Accusations, Sprout Studies
Apple’s Streaming Announcement, Duke Energy on Electric Vehicles, Bird and Lime leave Raleigh, IBM Accusations, and Sprout Pharmaceuticals Studies
Read More
Studies show Addyi, the ‘female Viagra,’ is safe with alcohol, Raleigh-based Sprout says
Three new studies affirm that Addyi, the so-called “female Viagra” from Raleigh based Sprout Pharmaceuticals, is safe and effective with alcohol even though the FDA warns against mixing the two, the company says.
Read More
Tech on Tap: Sprout CEO makes significant moves, people want to leave the Bay area, and privacy issues versus privacy innovation
Jason, Michael and Laura talk about the top stories on tap, the latest news from Amazon HQ2, and tease a new conversation with Robbie Allen of Infinia ML. The deep dive for the week is centered around privacy issues with Facebook and privacy safeguards announced by Apple at WWDC.
Read MoreSprout Pharmaceuticals relaunches ‘female Viagra’ at much lower price
Sprout Pharmaceuticals is relaunching the “little pink pill” Addyi – also known as the “female Viagra” at half the original price.
Read MoreValeant, with connections to Raleigh, will change name to Bausch Health
Valeant, the company whose enormous price increases on old drugs helped fuel public outrage over high drug costs and also bought then sold Raleigh-based Sprout Pharmaceuticals, is changing its name.
Read MoreSprout2: Reborn Sprout Pharmaceuticals draws 203 investors in $4.5M deal
Sprout Pharmaceuticals is getting back into business as Sprout2 with 203 investors lining up to launch the company that was sold just two years ago to Valeant Pharmaceuticals for $1 billion
Read More
